StemVax LLC

StemVax Therapeutics is a translational biotechnology company based in Chesterland, OH, specializing in the development of novel immunotherapies for brain tumor patients, particularly those with Glioblastoma. With a focus on cutting-edge research and creativity, StemVax aims to make a difference in the lives of brain cancer patients by offering highly effective immunotherapeutic approaches and targeting cancer stem cells and multi-resistant cancer cells.

Under the leadership of President Dr. Wheeler, who has over 30 years of immunology and neurology research experience, and Co-founder and Chief Scientific Officer Dr. Irvin, StemVax combines expertise in basic science and clinical research to drive the development of safe and efficacious novel immunotherapeutics. The company's dedication to advancing the field of immunotherapy for brain tumors is evident in their commitment to ongoing research and clinical trials, with the ultimate goal of bringing innovative therapies to market.

Generated from the website